Cleveland Cord Blood Center

The Cleveland Cord Blood Center (CCBC) is an independent, public cord blood bank. Since its founding in 2008, the not-for-profit 501(c)(3) collects, processes, stores and distributes stem-cell rich umbilical cord blood for transplantation in patients with life threatening disorders such as leukemia, lymphoma and immune system disorders. The Cleveland Cord Blood Center was founded by Mary J. Laughlin, M.D., who performed one of the world’s first successful umbilical cord blood stem cell transplants on an adult leukemia patient in 1995.

Mission
The Cleveland Cord Blood Center was established to meet Ohio’s need for umbilical cord blood-derived stem cells for use in both transplants and research. CCBC-collected cord blood reflects the area’s ethnically diverse population.

FDA Approval for CLEVECORD™

On September 1, 2016, the CCBC received a biologics license from the U.S. Food and Drug Administration (FDA) for CLEVECORD, a stem cell product derived from umbilical cord blood for use in stem cell transplants. The FDA approval of CLEVECORD reflects the organization’s ability to meet the highest quality standards in the industry for distribution of cord blood products to transplant centers throughout the U.S. and around the world.